GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Marketable Securities

SynCore Biotechnology Co (ROCO:4192) Marketable Securities : NT$6.66 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. SynCore Biotechnology Co's Marketable Securities for the quarter that ended in Mar. 2024 was NT$6.66 Mil.

SynCore Biotechnology Co's annual Marketable Securities stayed the same from Dec. 2021 (NT$6.66 Mil) to Dec. 2022 (NT$6.66 Mil) and stayed the same from Dec. 2022 (NT$6.66 Mil) to Dec. 2023 (NT$6.66 Mil).

SynCore Biotechnology Co Marketable Securities Historical Data

The historical data trend for SynCore Biotechnology Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Marketable Securities Chart

SynCore Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.66 6.66 6.66 6.66 6.66

SynCore Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.66 6.66 6.66 6.66 6.66

SynCore Biotechnology Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

SynCore Biotechnology Co  (ROCO:4192) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

SynCore Biotechnology Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

SynCore Biotechnology Co (ROCO:4192) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Marketable Securities
Comparable Companies
ROCO:6652 ROCO:6610 ROCO:6810 ROCO:6236 ROCO:6872 ROCO:6850 ROCO:4732 ROCO:6709 ROCO:6827 ROCO:6808 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
Website
https://www.syncorebio.com
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines